A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline FindingsNyaradzo Mgodi, Shelly Karuna, P. Andrew et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2021Cited by 45
A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline FindingsMark Anderson, Michal Juraska, Simbarashe Takuva et al.|UNC Libraries|2023Cited by 0